info icon

Carcinoma in situ of other/unspecified male genital organs

CD2_INSITU_MALE_GENITAL_NOS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only males

226837

2. Check conditions

None

226837

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D07.6&
  • Hospital discharge: ICD-9 2336
  • Cause of death: ICD-10 D07.6&
  • Cause of death: ICD-9 2336

2 out of 7 registries used, show all original rules.

11

4. Check minimum number of events

None

11

5. Include endpoints

None

11

6. Filter based on genotype QC (FinnGen only)

11

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D07
Name in latin
Carcinoma in situ organorum genitalium masculinorum aliorum sive non specificatorum

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 11 - 11
Unadjusted period prevalence (%) 0.00 - 0.00
Median age at first event (years) 68.59 - 68.59

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042936) Bacteria identified in Isolate by Culture
6
8
14.61
3.58
2.2
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
6
15
7.40
2.45
1.7
1.8
s
33.2
28.6
—
6
15
(3023368) Bacteria identified in Blood by Culture
6
20
5.30
1.91
4.2
4.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
5
15
5.17
1.74
4.4
6.4
mmol/l
103.8
103.1
—
5
15
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
5
17
4.48
1.56
2.6
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
26
3.82
1.18
1.7
3.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
5
23
3.12
0.90
1.8
2.3
u/l
913.8
135.7
—
5
23
(40758558) Short blood count panel - Blood
5
23
3.12
0.90
4.6
6.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
0
19
0.00
0.68
0.0
1.3
—
0.9
—
0
11
(3007164) IgA [Mass/volume] in Serum or Plasma
0
17
0.00
0.44
0.0
1.5
—
2.6
—
0
12
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
11
0.00
0.22
0.0
3.2
—
1.0
—
0
11
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
0
11
0.00
0.22
0.0
3.2
—
0.7
—
0
11
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
11
0.00
0.22
0.0
4.0
—
115.6
—
0
11
(3024354) Oxygen [Partial pressure] in Venous blood
0
11
0.00
0.22
0.0
4.6
—
4.9
—
0
11
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
9
0.00
0.00
0.0
4.8
—
0.1
—
0
9
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
0
7
0.00
0.00
0.0
6.3
—
1.2
—
0
7
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
7
0.00
0.00
0.0
6.9
—
61.4
—
0
7
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
6.0
—
23.1
—
0
7
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
10.0
—
111.3
—
0
8
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
7
0.00
0.00
0.0
1.6
—
262.7
—
0
7
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
37.0
—
0
7

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_INSITU_MALE_GENITAL_NOS – Carcinoma in situ of other/unspecified male genital organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).